DRUG-COATED BALLOONS HEALTHCARE PROFESSIONALS
<br><big>THINK </big><br> <big>LONG.</big>
The IN.PACT™ Admiral™ drug-coated balloon (DCB) is the only available DCB proven through 5 years.1ACCESS PRODUCT OVERVIEW
BEHIND THE OUTCOMES
IN.PACT Admiral DCB increases blood flow and reduces thickening of the artery wall by delivering the proven anti-proliferative drug paclitaxel to the vessel wall.
Average saved on follow-up costs through 2 years per patient with IN.PACT Admiral DCB versus standard PTA2
$2,984 vs. $4,196
Cost savings from the reduced rates of reintervention and higher rates of clinical efficacy make IN.PACT Admiral DCB the clear choice for patients and physicians.
Laird J. 5-year Results from the IN.PACT SFA Randomized Trial. Presented at VIVA 2018.
Cohen D. Economic Outcomes of Endovascular Femoropopliteal Intervention Using Drug-Coated Balloons vs Standard PTA: 2-Year Results From the IN.PACT SFA II Trial. Presented at: VIVA 15; Nov. 2-5, 2015; Las Vegas.